Medication 'Etamsilat'. Instructions for use

The medication "Etamsilat" instructions for use characterizes as a haemostatic agent. The drug is often prescribed in gynecology, during pregnancy with bleeding.

The medication "Etamsilat". Instructions for use: appointment

The drug is used to prevent or stop capillary bleeding in diabetic angiopathy, during surgical interventions in ENT practice (for tonsillectomy, for example), in ophthalmology for the removal of cataracts, keratoplasty, etc., in dentistry when removing teeth, cysts, granulomas. "Etamzilat" is recommended for use in urology (after prostatectomy, for example), gynecological practice and surgery (especially when interfering with abundantly supplied blood tissues), in emergency cases with pulmonary and intestinal bleeding, with hemorrhagic diathesis.

Means "Etamsilat". Instructions for use: the mechanism of action

The drug is able to increase the formation in the capillary walls of mucopolysaccharides with a large molecular mass, increase the stability of blood vessels, normalize their permeability against the background of pathological processes, improving microcirculation. Meat "Etamsilat" also has a haemostatic (hemostatic) property. This effect, according to experts, is based on the ability of the drug to activate the formation of thromboplastin. The drug has no effect on prothrombin time, does not provoke excessive coagulability, nor does it contribute to the formation of thrombi.

Dosing regimen

The drug "Etamsilat" is allowed to be used orally, intravenously, for the eyeball (retrobulbarno), under the eye (subconjunctival), intramuscularly.

When injected into a vein, the hemostatic (hemostatic) action of the drug is noted after five to fifteen minutes. Maximum efficiency is observed after an hour or two. Duration of the drug - from four to six hours. When injected into the muscle, the hemostatic effect is noted somewhat later. When administered orally, the action occurs after three hours.

In order to prevent bleeding an hour before surgery, Etamzylate (in ampoules) is administered intramuscularly or intravenously at a dosage of two to four milliliters (one or two ampoules). If necessary, the injection is repeated during the operation. Allowed before the operation (for three hours) instead of intravenous administration give two or three tablets. At an increased risk of postoperative bleeding for prophylaxis, an injection of 4-6 ml per day or six to eight tablets is given (evenly throughout the day).

To eliminate bleeding (for therapeutic purposes) inject (intramuscularly or intramuscularly) two or four milliliters at once, then every four to six hours two milliliters each. Subsequent injections may be replaced by oral administration of the preparation "Etamsilat".

Tablets should not be used for bleeding, triggered by the action of anticoagulants (drugs that stop blood clotting). With caution, prescribe the drug "Etamsilat" to patients with embolism or thrombosis (including in history).

Use of the drug may cause headache, minor dizziness, lowering of pressure, numbness in the lower extremities, flushing of the face, a feeling of heaviness in the epigastric region, heartburn.

In clinical practice cases of overdose with this drug are not described.

Synonyms of the drug "Etamsilat" - such medicines as "Impedil", "Cyclomine", "Aglumin" and others.